Merck & Co.
S&P 500
Dow Jones
$143.93
-0.54%
Delayed · cached 15 min
Fair value analysis
MRK
Merck & Co.
$143.93
Close used for this calculation
$103.74Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
61/100
Quality radar
Consensus fair value
$103.74
Above FV▼ -27.9% against the close used
Model range $39.53 – $145.60
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$39.53Fair value$103.74Bull$145.60
FairClose
52-week traded range
52W low $77.6052W high $156.45
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Merck & Co. closed at $143.93, 38.7% above the consensus fair value of $103.74 drawn from 9 valuation models.
Financial DNA score 61/100 — Good. P/E of 19.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$79.70
-44.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=5.4%, r=10%, tg=3%, n=10yr
Graham Number
$52.73
-63.4%
√(22.5 × EPS × BVPS)
EPS=7.28, BVPS=16.97 · outside Graham range (P/E 19.8, P/B 8.5) — asset-light, treat as a rough floor
P/E Fair Value
$145.60
+1.2%
EPS × 20x (sector P/E)
EPS=7.28, Sector P/E=20x
Peter Lynch (PEG)
$39.53
-72.5%
EPS × Growth% (PEG = 1 is fair)
EPS=7.28, g=5.4%
EV/EBITDA
$108.52
-24.6%
(EBITDA × 12.7x − Net Debt) ÷ Shares
EBITDA=24.11B
Dividend Discount (DDM)
$75.71
-47.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=3.28, r=10%, g=5.4%
Book Value (P/B)
$141.50
-1.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=16.97, ROE=43.5%, g=5.4%, r=10%
Reverse DCF
$143.93
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7% | Historical: 5.4%
Margin of Safety
$69.51
-51.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=92.68, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.